Cargando…
Disruption of Planar Cell Polarity Pathway Attributable to Valproic Acid-Induced Congenital Heart Disease through Hdac3 Participation in Mice
BACKGROUND: Valproic acid (VPA) exposure during pregnancy has been proven to contribute to congenital heart disease (CHD). Our previous findings implied that disruption of planar cell polarity (PCP) signaling pathway in cardiomyocytes might be a factor for the cardiac teratogenesis of VPA. In additi...
Autores principales: | Duan, Hong-Yu, Zhou, Kai-Yu, Wang, Tao, Zhang, Yi, Li, Yi-Fei, Hua, Yi-Min, Wang, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111683/ https://www.ncbi.nlm.nih.gov/pubmed/30127218 http://dx.doi.org/10.4103/0366-6999.239311 |
Ejemplares similares
-
Planar Cell Polarity Signaling Pathway in Congenital Heart Diseases
por: Wu, Gang, et al.
Publicado: (2011) -
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
por: Pitt, Bertram, et al.
Publicado: (2021) -
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
por: Zhang, Zhihua, et al.
Publicado: (2013) -
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007) -
HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
por: Tian, Shuo, et al.
Publicado: (2018)